Belsomra is prescribed to treat insomnia [1]. It is particularly used for individuals who have difficulty falling asleep and/or staying asleep [1].
How does Belsomra work to help with sleep?
Belsomra, with the active ingredient suvorexant, is a dual orexin receptor antagonist [2]. Orexins are neurotransmitters that play a role in promoting wakefulness [2]. By blocking the action of orexins, Belsomra reduces the brain's stimulation of wakefulness, thereby facilitating sleep [2].
What are the side effects of Belsomra?
Common side effects of Belsomra can include sleep paralysis, abnormal dreams, and drowsiness [3]. Some patients may also experience daytime impairment, headaches, and temporary memory issues [3]. It is important to discuss potential side effects with a healthcare provider [3].
When does Belsomra's patent expire?
Information on Belsomra's patent expiry is available through resources like DrugPatentWatch.com [4]. Patent expiration dates are critical for understanding when generic versions of a drug may become available [4].
Who makes Belsomra?
Belsomra is manufactured by Merck & Co., Inc. [1].
What are the different strengths of Belsomra available?
Belsomra is available in several dosage strengths, typically ranging from 5 mg to 20 mg [1]. The specific strength prescribed depends on individual patient needs and medical advice [1].
Are there alternatives to Belsomra for insomnia?
Yes, various other medications and non-pharmacological approaches are used to treat insomnia. These can include other classes of sleep medications like benzodiazepines, non-benzodiazepine hypnotics (e.g., zolpidem), and certain antidepressants. Cognitive Behavioral Therapy for Insomnia (CBT-I) is also a widely recommended non-drug treatment [5].
What is the cost of Belsomra?
The cost of Belsomra can vary based on dosage, insurance coverage, and pharmacy [6]. Patients may explore manufacturer coupons or patient assistance programs for potential cost reductions [6].
What are the clinical trial results for Belsomra?
Clinical trials for Belsomra have demonstrated its efficacy in improving sleep onset and sleep maintenance in adults with insomnia [2]. These studies have been crucial in establishing its safety and effectiveness profile [2].
What does the research say about Belsomra's long-term use?
Ongoing research and post-market surveillance continue to evaluate the long-term effects and safety of Belsomra [2].
Can Belsomra be used by children?
Belsomra is approved for use in adults [1]. Its use in pediatric populations is not indicated without specific medical consultation and is subject to further research and regulatory approval [1].
---
Sources
1. Belsomra [Prescribing Information]. Merck & Co., Inc.; 2023.
2. Dresler, M., et al. (2017). Efficacy and tolerability of suvorexant in patients with moderate-to-severe chronic insomnia disorder: a randomized, double-blind, placebo-controlled trial. Sleep Medicine, 38, 107-115.
3. Belsomra (suvorexant) side effects. Mayo Clinic. Accessed October 26, 2023.
4. DrugPatentWatch.com. (n.d.). Belsomra Patent Information.
5. Riemann, D., et al. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(4), 479-501.
6. Belsomra Prices, Coupons & Patient Assistance Programs. Drugs.com. Accessed October 26, 2023.